Clinical Trial Update: Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin and paclitaxel with or without avelumab in advanced or recurrent endometrial cancer. Status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Avelumab (avelumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Endometrial Cancer | Phase 2 | Status: UNKNOWN